TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
暂无分享,去创建一个
Huaxi Xu | G. Bu | Chia-Chen Liu | J. Fryer | Yun-wu Zhang | Honghua Zheng | Xin Wang | Lin Jia | Z. Rong | Li Zhong | Xiao-Fen Chen | Longyu Yang
[1] J. Grutzendler,et al. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy , 2016, Neuron.
[2] L. Gan,et al. Targeting microglia for the treatment of Alzheimer's Disease , 2016, Glia.
[3] Huaxi Xu,et al. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation , 2016, Neurobiology of Aging.
[4] D. Holtzman,et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.
[5] M. Colonna,et al. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis , 2016, Nature Reviews Neuroscience.
[6] D. Holtzman,et al. TREM2 Function in Alzheimer's Disease and Neurodegeneration. , 2016, ACS chemical neuroscience.
[7] Manasi Malik,et al. Genetics ignite focus on microglial inflammation in Alzheimer’s disease , 2015, Molecular Neurodegeneration.
[8] Huaxi Xu,et al. TREM2 in CNS homeostasis and neurodegenerative disease , 2015, Molecular Neurodegeneration.
[9] M. Colonna,et al. TREM2 sustains microglial expansion during aging and response to demyelination. , 2015, The Journal of clinical investigation.
[10] Junjie Xing,et al. The TREM2-DAP12 signaling pathway in Nasu–Hakola disease: a molecular genetics perspective , 2015, Research and reports in biochemistry.
[11] R. Ransohoff,et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.
[12] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[13] M. Xie,et al. TREM2 regulates microglial cell activation in response to demyelination in vivo , 2015, Acta Neuropathologica.
[14] J. Rogers,et al. Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease , 2014, Neuron.
[15] F. Ginhoux,et al. Microglia modulate wiring of the embryonic forebrain. , 2014, Cell reports.
[16] S. Hickman,et al. TREM2 and the neuroimmunology of Alzheimer's disease. , 2014, Biochemical pharmacology.
[17] J. A. Rı́o,et al. Glycogen Synthase Kinase 3 Beta (GSK3β) at the Tip of Neuronal Development and Regeneration , 2014, Molecular Neurobiology.
[18] Yongjian Wu,et al. TREM‐2 Promotes Macrophage‐Mediated Eradication of Pseudomonas aeruginosa via a PI3K/Akt Pathway , 2014, Scandinavian journal of immunology.
[19] W. Hahn,et al. Genomic insights into WNT/β-catenin signaling. , 2014, Trends in pharmacological sciences.
[20] Toshiro K. Ohsumi,et al. The Microglial Sensome Revealed by Direct RNA Sequencing , 2013, Nature Neuroscience.
[21] T. Bird. TREM2 and neurodegenerative disease. , 2013, The New England journal of medicine.
[22] J. Hardy,et al. TREM2 and neurodegenerative disease. , 2013, The New England journal of medicine.
[23] V. Gallo,et al. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation. , 2013, Cancer letters.
[24] L. Hazlett,et al. TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. , 2013, Investigative ophthalmology & visual science.
[25] V. Martínez‐Cerdeño,et al. Microglia Regulate the Number of Neural Precursor Cells in the Developing Cerebral Cortex , 2013, The Journal of Neuroscience.
[26] J. Relton,et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival , 2013, The Journal of experimental medicine.
[27] A. Aguzzi,et al. Microglia: Scapegoat, Saboteur, or Something Else? , 2013, Science.
[28] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[29] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[30] N. Zaffaroni,et al. Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway. , 2012, Current pharmaceutical design.
[31] B. Schmidt,et al. Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models , 2012, International journal of Alzheimer's disease.
[32] Hans Clevers,et al. Wnt/β-Catenin Signaling and Disease , 2012, Cell.
[33] Hiroshi Takayanagi,et al. TREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis , 2012, The Journal of Immunology.
[34] Jie Zhu,et al. Kainic Acid-Induced Neurodegenerative Model: Potentials and Limitations , 2010, Journal of biomedicine & biotechnology.
[35] E. Polazzi,et al. Microglia and neuroprotection: From in vitro studies to therapeutic applications , 2010, Progress in Neurobiology.
[36] Wei Wang,et al. Excitotoxicity of TNFα derived from KA activated microglia on hippocampal neurons in vitro and in vivo , 2010, Journal of neurochemistry.
[37] G. Landreth,et al. The role of microglia in amyloid clearance from the AD brain , 2010, Journal of Neural Transmission.
[38] K. Basler,et al. β-Catenin hits chromatin: regulation of Wnt target gene activation , 2009, Nature Reviews Molecular Cell Biology.
[39] V. Perry,et al. Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.
[40] F. Rossi,et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.
[41] L. Peltonen,et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts , 2005, Neurology.
[42] P. Salinas,et al. Signalling in neural development: WNTS in the vertebrate nervous system: from patterning to neuronal connectivity , 2005, Nature Reviews Neuroscience.
[43] Masahide Takahashi,et al. Amyloid‐β peptides induce cell proliferation and macrophage colony‐stimulating factor expression via the PI3‐kinase/Akt pathway in cultured Ra2 microglial cells , 2005, FEBS letters.
[44] Sunhee C. Lee,et al. Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt1 , 2005, The Journal of Immunology.
[45] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[46] I. Han,et al. TGF-β1 Represses Activation and Resultant Death of Microglia via Inhibition of Phosphatidylinositol 3-Kinase Activity1 , 2004, The Journal of Immunology.
[47] Amie Y Lee,et al. Inhibition of Wnt-1 Signaling Induces Apoptosis in β-Catenin-Deficient Mesothelioma Cells , 2004, Cancer Research.
[48] M. Colonna. TREMs in the immune system and beyond , 2003, Nature Reviews Immunology.
[49] L. Peltonen,et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.
[50] Marty W. Mayo,et al. WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.
[51] R. Bernards,et al. Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage , 2000, Cell.
[52] J. Papkoff,et al. WNT-1 and HGF Regulate GSK3β Activity and β-Catenin Signaling in Mammary Epithelial Cells , 1998 .
[53] Stephen W. Byers,et al. Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin* , 1997, The Journal of Biological Chemistry.
[54] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[55] Lewis C Cantley,et al. PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.
[56] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[57] D. Dickson,et al. Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. , 1994, The American journal of pathology.
[58] V. Perry,et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain , 1990, Neuroscience.
[59] H. Chui,et al. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease , 1990, Neuroscience Letters.
[60] M. Arfan Ikram,et al. Variant of TREM 2 Associated with the Risk of Alzheimer ’ s Disease , 2012 .
[61] A. Singleton,et al. TREM2 Variants in Alz hei mer's Disease , 2012 .
[62] M. Block,et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.
[63] H. Clevers. Wnt/beta-catenin signaling in development and disease. , 2006, Cell.
[64] K. Maiese,et al. Winding through the WNT pathway during cellular development and demise. , 2006, Histology and histopathology.
[65] L. Peltonen,et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. , 2005, Neurology.
[66] J. Papkoff,et al. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. , 1998, Biochemical and biophysical research communications.
[67] B. Hyman,et al. Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.
[68] R Kemler,et al. beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.
[69] S. Byers,et al. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. , 1997, The Journal of biological chemistry.